Home FDA labels 2b39daef-65ee-0aa7-e063-6394a90a364d 0.9% SODIUM CHLORIDE openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name 0.9% SODIUM CHLORIDE
Generic name 0.9% SODIUM CHLORIDE
Manufacturer HF Acquisition Co LLC, DBA HealthFirst
Product type HUMAN PRESCRIPTION DRUG
SPL set ID 8dfb05c0-77e8-2fa1-e053-2a95a90a3d33
SPL ID 2b39daef-65ee-0aa7-e063-6394a90a364d
Version 3
Effective date 2025-01-08
Source export date 2026-10-27
Source partition 3
Source file https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-27/d7629e6f844435cfe6cb0cf8c5341c46775ea16c5af42c77a22a2ffe820a2cd2/drug-label-0003-of-0014.json.zip
Source manifest SHA-256 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run 20261027T193451Z
Imported at 2026-10-27 19:49:17 Harmonized routes table Harmonized routes INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 12 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 1 matching rows.
adverse reactions ADVERSE REACTIONS Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.